These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 19702110)
1. Low and high density lipoprotein--cholesterol and coronary atherothrombosis. Kanjuh V; Ostojić M; Lalić N; Stokić E; Adić-Cemerlić N; Gojković-Bukarica L Med Pregl; 2009; 62 Suppl 3():7-14. PubMed ID: 19702110 [TBL] [Abstract][Full Text] [Related]
2. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?]. Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606 [TBL] [Abstract][Full Text] [Related]
4. [Physiology and pathophysiology of the metabolism of lipoproteins]. Sandhofer F Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930 [TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol. Tani S; Nagao K; Hirayama A Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320 [TBL] [Abstract][Full Text] [Related]
6. Utility of Lp-PLA2 in lipid-lowering therapy. Racherla S; Arora R Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673 [TBL] [Abstract][Full Text] [Related]
7. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Koenig W Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367 [TBL] [Abstract][Full Text] [Related]
8. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
9. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans. Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454 [TBL] [Abstract][Full Text] [Related]
10. Oxidized LDL and HDL: antagonists in atherothrombosis. Mertens A; Holvoet P FASEB J; 2001 Oct; 15(12):2073-84. PubMed ID: 11641234 [TBL] [Abstract][Full Text] [Related]
11. [Lp-PLA2, a biomarker of vascular inflammation and vulnerability of atherosclerosis plaques]. Bonnefont-Rousselot D Ann Pharm Fr; 2016 May; 74(3):190-7. PubMed ID: 26499399 [TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a), cardiovascular disease, and contemporary management. Jacobson TA Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706 [TBL] [Abstract][Full Text] [Related]
14. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis. Staprans I; Pan XM; Rapp JH; Feingold KR Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280 [TBL] [Abstract][Full Text] [Related]